Diagnostic utility of the Paris system for urine cytology with histopathological correlation

Komal Patel; Pinkal Shah; Riddhi Patel; R. N. Hathila; Archana Patel

doi:10.18203/2320-6012.ijrms20263518

Authors

Komal Patel Department of Pathology, Government Medical College, Surat, Gujrat, India
Pinkal Shah Department of Pathology, Government Medical College, Surat, Gujrat, India
Riddhi Patel Department of Pathology, Government Medical College, Surat, Gujrat, India
R. N. Hathila Department of Pathology, Government Medical College, Surat, Gujrat, India
Archana Patel Department of Pathology, Government Medical College, Surat, Gujrat, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20263518

Keywords:

Paris system, Urothelial carcinoma, Cytology

Abstract

Background: Urothelial carcinoma (UC) is the second most common malignancy in the urogenital system. Urinary cytology is a non-invasive, cost-effective screening and monitoring technique for UC.

Methods: In this retrospective study, conducted from over a period of one year, 62 urine cytology sample s were evaluated utilizing. The Paris system (TPS) for reporting urinary cytology and correlated with histopathological findings where available.

Results: Urine cytological cases were divided in 5 categories as per TPS. The majority (46.77%) were negative for high-grade urothelial carcinoma (NHGUC), while 35.48% were unsatisfactory/non-diagnostic, indicating inadequate samples. 6.45% of cases were diagnosed as high-grade urothelial carcinoma (HGUC), and 4.83% were suspicious for high-grade urothelial carcinoma (SHGUC). Atypical urothelial cells (AUC) made up 6.45% of cases. No any case of low-grade urothelial neoplasm was found. Out of 62 total cases, histological correlation was available in 13. On histopathology 8 cases confirmed as UC which were diagnosed cytologically as HGUC (2 cases), SHGUC (1 case), AUC (3 cases) and NHGUC (2 cases). Two cases were nondiagnostic on cytology due to low cellularity were later reported as Sarcomatoid urothelial carcinoma with squamous component and Low-grade urothelial carcinoma each on histology. Remaining biopsies were inadequate where only necrosis and/or few atypical cells noted.

Conclusions: The study highlights the effectiveness of urine cytology in detecting high-grade lesions but emphasizes the challenges posed by unsatisfactory samples and the need for a multi-modal diagnostic approach, including cystoscopy and histopathology, to enhance diagnostic accuracy. The TPS framework offers a structured method for interpreting urinary cytology, critical for improving patient outcomes in urothelial carcinoma detection.

References

Wojcik EM, Kurtycz DF, Rosenthal DL. The Paris system for reporting urinary cytology. 2022.

Jaiswal DG, Dakhure SD. Utility of urine cytology in urinary tract neoplasm with histopathological correlation. Int J Sci Healthc Res. 2019;4:199-204.

Yuan L, Gero M, Zia S, Aryal SC, Shetty S, Reynolds JP. Cyto‐histo correlation and false‐negative urine: Before and after the Paris system for reporting urinary cytology. Diagnos Cytopathol. 2022;50(8):404-10.

Wintzingerode F, Göbel UB, Stackebrandt E. Determination of microbial diversity in environmental samples: pitfalls of PCR-based rRNA analysis. FEMS Microbiol Rev. 1997;21(3):213-29.

Zare S, Mirsadraei L, MD, Niloufar Reisian, MD. Correlation of Cytology and Histology in 194 Cases. Am J Clin Pathol. 2018;150:162-7.

Gaikwad VP, Naik LP. The Paris System for urine cytology: a 2 years’ experience from western Indian population. Arch Med Health Sci. 2023;11(2):203-8.

Kafle N, Sinha A, Sedhain S, Bhattarai S. Utility of urine cytology as per the Paris System in patients attending Birat Medical College. Nepal J Med Sci. 2025;10(2):50–60.

Nikas IP, Seide S, Proctor T, Kleinaki Z, Kleinaki M, Reynolds JP. The Paris system for reporting urinary cytology: a meta-analysis. J Pers Med. 2022;12(2):170.

Stanzione N, Ahmed T, Fung PC, Cai D, Lu DY, Sumida LC. The continual impact of the Paris System on urine cytology, a 3‐year experience. Cytopathology. 2020;31(1):35-40.

Pastorello MR, Barkan MG. Experience on the use of the Paris system for reporting urinary cytopathology: review of the published literature. J American Soc Cytopathol. 2021;10(1):79-87.

Arya J, Singh J, Khanna SP. Evaluation of the Paris system for reporting urinary cytology in the diagnosis of urothelial malignancies: a histopathological correlation study. Int J Drug Deliv Technol. 2026;16(49):1364-75.

Rai S, Lali BS, Venkataramana CG, Philipose CS, Rao R, Prabhu GGL. A quest for accuracy: evaluation of the Paris system in diagnosis of urothelial carcinomas. J Cytol. 2019;36(3):169-73.